Filter results: News Clear filters
Filters

215 results

Sort ·
Order ·

FMD Safety Features version 9: the European Commission Q&A on safety features for medicinal products for human use

29th March 2018 · The European Commissionfor medicinal products for human use has published version 9 of their Q&A on safety features on their website. This new version includes…

Community Services PGD Audit Standards and Tool - a shared example

28th February 2018 · Essex Partnership University NHS Foundation Trust Community Services have shared their PGD Audit Standards and Audit Tools for adaptation by other Trusts.  There is a…

PHE PGD template combined hepatitis A virus (inactivated) and typhoid polysaccharide vaccine

26th February 2018 · PHE have published a PGD template to support the administration of combined hepatitis A virus (inactivated) and typhoid polysaccharide vaccine to individuals considered at risk…

PHE patient group direction (PGD) template - administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to Salmonella enterica serovar typhi (S. typhi)

26th February 2018 · PHE Have published a patient group direction (PGD) template which supports the administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to…

In use product safety assessment report: Onexila® XL (oxycodone once daily prolonged release tablets)

29th January 2018 · A UKMi Product Safety assessment on Onexila® XL (oxycodone once daily prolonged release tablets); in-use medication safety considerations resultant from the product presentation or other…

Oxford University Hospitals NHS Foundation Trust Patient Group Direction (PGD) Policy, Proposal Form and Audit Tool

29th January 2018 · The purpose of this PGD Policy, Proposal Form and Audit Tool produced by Oxford University Hospitals NHS Foundation Trust is to ensure compliance with NICE MPG2 PGDs recommendations…

Discussion sheets from first wave of Regional Medicines Optimisation Committee meetings

18th January 2018 · Four Regional Medicines Optimisation Committees exist for England, with one sited in each of the NHS England regional geographies (The North, Midlands and the East,…

NPSG Guidance for Chief Pharmacists: Non-Disclosure Agreements with medicines manufacturers (December 2017)

18th December 2017 · This National Pharmaceutical Supply Group (NPSG) statement sets out the recommended position for NHS Hospital Trust Chief Pharmacists in the event of a request from…

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR TRUXIMA®▼ AND RIXATHON®▼ (RITUXIMAB BIOSIMILARs)

20th November 2017 · This review discusses practical safety considerations associated with the introduction of the two biosimilar rituximab products.  

Medicines Manufacturing in Puerto Rico: impact assessment by DH Medicines Supply Team November 2017

13th November 2017 · Latest information available to the DH Medicines supply team does not suggest that infrastructure damage cause by hurricane Maria is likely to cause any significant…

Filters (1) Toggle

Load: 1 queries - 297ms - 39.8MB - 299 cache hits / 299
Query: 2 queries - 300ms - 36.8MB - 322 cache hits / 322
Display: 34 queries - 684ms - 42.8MB - 1701 cache hits / 1743